M&G Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$31.2M Buy
173,266
+7,325
+4% +$1.33M 0.11% 101
2023
Q3
$29.9M Buy
165,941
+20,455
+14% +$4.05M 0.13% 101
2023
Q2
$25.9M Buy
145,486
+7,844
+6% +$1.81M 0.1% 113
2023
Q1
$29.7M Buy
137,642
+13,038
+10% +$3.13M 0.14% 107
2022
Q4
$27.4M Buy
124,604
+23,721
+24% +$4.35M 0.14% 113
2022
Q3
$13.6K Sell
100,883
-10,977
-10% -$1.89M 0.08% 151
2022
Q2
$18.1K Buy
111,860
+47,031
+73% +$7.35M 0.11% 149
2022
Q1
$12.3K Buy
64,829
+51,310
+380% +$10.9M 0.02% 186
2021
Q4
$3.66K Sell
13,519
-5,373
-28% -$1.81M 0.01% 270
2021
Q3
$6.86K Buy
18,892
+8,206
+77% +$2.68M 0.02% 341
2021
Q2
$3.67K Buy
10,686
+56
+0.5% +$18.5K 0.01% 440
2021
Q1
$3.7K Sell
10,630
-15,016
-59% -$4.97M 0.01% 251
2020
Q4
$6.62K Buy
25,646
+2,624
+11% +$722K 0.04% 214
2020
Q3
$6.58M Sell
23,022
-19,141
-45% -$4.5M 0.07% 200
2020
Q2
$7.93M Buy
42,163
+25,391
+151% +$4.13M 0.08% 179
2020
Q1
$2.06M Buy
16,772
+9,497
+131% +$1.49M 0.03% 252
2019
Q4
$1.21M Buy
+7,275
New +$1.21M 0.01% 310

Other funds holding ONC

M&G Investment Management's ONC Position: Q4 2023 in Review

M&G Investment Management increased its BeOne Medicines Ltd (ONC) stake by 4.4% in Q4 2023, buying an estimated $1.33M and bringing the position to 173,266 shares worth $31.2M. The position accounts for 0.11% of the portfolio, ranked #101.

M&G Investment Management first reported a position in ONC in Q4 2019 and has held it in 17 quarters since. 204 funds tracked by Wall St. Rank hold ONC as of Q4 2023.

  • M&G Investment Management held 173,266 shares of BeOne Medicines Ltd worth $31.2M as of Q4 2023.
  • M&G Investment Management bought 7,325 BeOne Medicines Ltd shares in Q4 2023, an estimated $1.33M.
  • BeOne Medicines Ltd made up 0.11% of M&G Investment Management's portfolio in Q4 2023, its #101 holding.
  • M&G Investment Management first reported a position in BeOne Medicines Ltd in Q4 2019 and has held it in 17 quarters since.
  • 204 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2023.

Based on M&G Investment Management's 13F filing for Q4 2023, filed 8 Feb 2024.